Abstract
We reviewed the use of oral dichloroacetate (DCA) in the treatment of children with congenital lactic acidosis caused by mutations in the pyruvate dehydrogenase complex (PDC). The case histories of 46 subjects were analyzed with regard to diagnosis, clinical presentation and response to DCA.
DCA decreased blood and cerebrospinal fluid lactate concentrations, and was generally well tolerated. DCA may be particularly effective in children with PDC deficiency by stimulating residual enzyme activity and, consequently, cellular energy metabolism.
A controlled trial is needed to determine the definitive role of DCA in the management of this devastating disease.
POSTDOCTORAL FELLOW NEEDED NEUROIMAGING PROJECTS
"How I Got Approved for Social Security Disability for Fibromyalgia"Real-life Social Security Disability success stories for Fibro
Sample Doctors Letters for Disability for Myalgic Encephalomyelitis and Chronic Fatigue SyndromeFor Myalgic Encephalomyelitis, Chronic Fatigue Syndrome & Related Conditions
My post-exertional malaise has completely disappeared with liver flushes!Maybe you can too?
![ME/CFS lecture | Dr Nancy Klimas | 2011 [Chronic Fatigue Syndrome / SEID / New Zealand] - YouTube](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
